10 percent Owner of Biomea Fusion Sold 8.58M In Stock By Benzinga - Investing.com UK
| SCCC Stock | USD 24.50 0.08 0.33% |
About 62% of all Sachem Capital's shareholders are looking to take a long position. The current sentiment regarding investing in Sachem Capital Corp stock implies that some traders are interested. The current market sentiment, together with Sachem Capital's historical and current headlines, can help investors time the market. In addition, many technical investors use Sachem Capital Corp stock news signals to limit their universe of possible portfolio assets.
Sachem |
10 percent Owner of Biomea Fusion Sold 8.58M In Stock By Benzinga Investing.com UK
Read at news.google.com
 |
Sachem Capital Fundamental Analysis
We analyze Sachem Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sachem Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sachem Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Sachem Capital is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Sachem Capital Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sachem Capital stock to make a market-neutral strategy. Peer analysis of Sachem Capital could also be used in its relative valuation, which is a method of valuing Sachem Capital by comparing valuation metrics with similar companies.
Peers
Sachem Capital Related Equities
| SACC | Sachem Capital | 0.20 | ||||
| HROWL | Harrow Health | 0.04 | ||||
| BWSN | Babcock Wilcox | 1.21 |
Complementary Tools for Sachem Stock analysis
When running Sachem Capital's price analysis, check to measure Sachem Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sachem Capital is operating at the current time. Most of Sachem Capital's value examination focuses on studying past and present price action to predict the probability of Sachem Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sachem Capital's price. Additionally, you may evaluate how the addition of Sachem Capital to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |